Cyberknife Precision Radiation Delivery System for Tumors of the Spine

Not Recruiting

Trial ID: NCT00185666

Age - 5 Years-N/A Condition - Brain (Central Nervous System, CNS) Cancers, Pediatric Cancer, Spinal Cord Cancer, Spinal Tumor Gender - ALL Accepting Healthy Volunteers - No

Purpose

The purpose of this study is to determine the usefulness of Cyberknife precision radiation in eliminating or preventing the further growth of spinal tumors and lesions.

Official Title

Cyberknife Precision Radiation Delivery System for Tumors of the Spine

Stanford Investigator(s)

Iris C. Gibbs, MD, FACR, FASTRO
Iris C. Gibbs, MD, FACR, FASTRO

Professor of Radiation Oncology (Radiation Therapy) and, by courtesy, of Neurosurgery

Eligibility

Inclusion Criteria:- Intra-axial, extra-axial, or vertebral spinal lesion

* Age \> 5
* Histologic confirmation of malignant primary lesion or radiographic diagnosis of benign or vascular spinal lesion
* No rapidly deteriorating symptoms of spinal cord compression
* No instability of the spine
* Life expectancy \> 6 months Exclusion Criteria:- Patients without tumors of the spine
* Patients younger than 5 years old

View More
View Less

Intervention(s):

procedure: Stereotactic radiosurgery

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Laurie Tupper
6507361694

New Trial Alerts

©2024 Stanford Medicine